# Biovex, Inc. – FDA Inspection, Mar 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/biovex-inc/ef59841b-155c-4ce8-b081-c990d3d6d0aa
Source feed: FDA_Inspections

> FDA inspection 1012905 of Biovex, Inc., March 16, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012905
- Company Name: Biovex, Inc.
- Inspection Date: 2017-03-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1109494 - 2019-09-27](https://www.keypedia.com/records/fda_inspections/biovex-inc/4db75d39-d8f4-42d3-b442-ca0501cb7396)

## Related Officers

- [Investigator](https://www.keypedia.com/people/michele-l-forster/5e4b6db7-412f-4e4f-87a9-8af15a16429f)
- [FDA Associated Person](https://www.keypedia.com/people/mihaly-s-ligmond/2904ef70-a757-49c7-9ac4-a2c07ee36001)

Company: https://www.keypedia.com/companies/biovex-inc/796f9894-ce55-4789-9665-b70237ceb306

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
